MetaCap

Black Diamond Therapeutics Statistics

NASDAQ: BDTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.31-0.08 (-5.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Black Diamond Therapeutics by the numbers

Black Diamond Therapeutics has a market capitalization of $75.3 million based on 57.47M shares outstanding. With trailing EPS of $-0.77, Black Diamond Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.8% below its 50-day average and 38.3% below its 200-day average.

Average daily trading volume is 697.70K shares, or about $913,987 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BDTX valuation vs. peer median

BDTX compared with the median of 8 peer companies
MetricBDTXPeer medianDifference
Market cap$75.28M$64.91M+16%
Avg. volume697.70K1.35M-48%

Peer median across 8 companies: CRDF, TNYA, ATRA, NMRA, ZURA, CSBR, LENZ, CHRS.

Valuation

Market cap
$75.28M
Price / sales (latest FY)
1.08
EPS (TTM)
$-0.77

Price and trading

Previous close
1.39
Open
1.33
Day range
1.31 – 1.41
52-week range
1.31 – 3.97
52-week change
-65.53%
Beta
—
Volume
663.19K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
75.28M
Forward Pe
-1.32
Eps
-0.77
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.97
Week52 Low
1.31
Avg Volume
697.70K
Shares Outstanding
57.47M
Ma50
1.79
Ma200
2.12
Earnings Date
Nov 10, 2026
Pct From52w High
-67.00%
Pct From52w Low
0.00%

Related